Find a Cancer Provider

Are you a referring physician?
I am searching for a
Edward A. Stadtmauer, MD

Edward A. Stadtmauer, MD Physician

Section Chief, Hematologic Malignancies
Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Stadtmauer is a Penn Medicine employed physician.

About Dr. Edward A. Stadtmauer

Recognized annually in Philadelphia Magazine's Top Docs issue from 2005 - 2008, 2011, 2013 - 2015

Recognized by America's Top Doctors, 2007, 2008, 2010, 2011-14

Recognized by Best Doctors in America 2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012, 2013-2014

Clinical Specialties


  • Medicine
    • Hematology
    • Medical Oncology

Programs & Centers:

  • Cancer
    • Amyloidosis Program
    • Bone Marrow Transplant and Stem Cell Transplant Program
    • Leukemia Program
    • Lymphoma Program
    • Multiple Myeloma Program
  • Hematology
    • Classical (Non-Malignant) Hematology Program

Board Certification:

  • Hematology, 1988
  • Internal Medicine, 1986
  • Medical Oncology, 1989

Clinical Expertise:

  • Autologous Stell Cell Transplantation
  • Blood Cancer
  • Bone Marrow Transplant
  • Multiple Myeloma

Description of Clinical Expertise

Myeloma, Leukemia, Lymphoma and Bone Marrow and Stem Cell Transplant

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: University of Pennsylvania School of Medicine
Residency: Bronx Municipal Hospital - Albert Einstein College
Fellowship: Hospital of the University of Pennsylvania


American College of Physicians, Fellow, National American Federation for Clinical Research, National American Society for Blood and Marrow Transplantation, National American Society of Clinical Oncology, National American Society of Hematology, National Autologous Bone Marrow Transplant Registry (ABMTR/CIBMTR), National Bone Marrow Transplant Clinical Trials Network, National Eastern Cooperative Oncology Group, National Foundation for the Accreditation of Hematopoietic Cell Therapy, National International Myeloma Working Group, International Membership in National Scientific Review Panels, National NIAID Hematopoietic Stem Cell Transplantation Data Safety Monitoring Board (HSCT DSMB), National

Hospital Affiliation

Dr. Stadtmauer is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Clinical trials, Bone Marrow Transplant

Selected Publications:

Garfall, Alfred L; Maus, Marcela V; Hwang, Wei-Ting; Lacey, Simon F; Mahnke, Yolanda D; Melenhorst, J Joseph; Zheng, Zhaohui; Vogl, Dan T; Cohen, Adam D; Weiss, Brendan M; Dengel, Karen; Kerr, Naseem D S; Bagg, Adam; Levine, Bruce L; June, Carl H; Stadtmauer, Edward A.: Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma. New England Journal of Medicine 373 (11): 1040-7,2015.

Rapoport, Aaron P; Stadtmauer, Edward A; Binder-Scholl, Gwendolyn K; Goloubeva, Olga; Vogl, Dan T; Lacey, Simon F; Badros, Ashraf Z; Garfall, Alfred; Weiss, Brendan; Finklestein, Jeffrey; Kulikovskaya, Irina; Sinha, Sanjoy K; Kronsberg, Shari; Gupta, Minnal; Bond, Sarah; Melchiori, Luca; Brewer, Joanna E; Bennett, Alan D; Gerry, Andrew B; Pumphrey, Nicholas J; Williams, Daniel; Tayton-Martin, Helen K; Ribeiro, Lilliam; Holdich, Tom; Yanovich, Saul; Hardy, Nancy; Yared, Jean; Kerr,: NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nature Medicine 21 (8): 914-21,2015.

Waxman, A J; Mick, R; Garfall, A L; Cohen, A; Vogl, D T; Stadtmauer, E A; Weiss, B M.: Classifying ultra-high risk smoldering myeloma. Leukemia 29 (3): 751-3,2015.

Frosch, Zachary; Luskin, Marlise R; Landsburg, Daniel J; Schuster, Stephen J; Svoboda, Jakub; Loren, Alison W; Porter, David L; Stadtmauer, Edward A; Nasta, Sunita D.: R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma. Clinical lymphoma, myeloma & leukemia 15 (2): 92-7,2015.

Freytes, Cesar O; Toro, Juan J; Yeh, Rosa F; Stadtmauer, Edward A; Ratanatharathorn, Voravit; Akpek, Gorgun; Sahovic, Entezam; Tricot, Guido J; Shaughnessy, Paul J; White, Darrell J; Rodriguez, Tulio E; Solomon, Scott R; Yu, Louie H; Zhao, Cathy; Patil, Shiva; Armstrong, Elizabeth; Smith, Angela; Elekes, Agnes; Kato, Kazunobu; Reece, Donna E.: Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation. Biology of Blood & Marrow Transplantation 20 (12): 1949-57,2014.

Landsburg, Daniel J; Vogl, Dan T; Plastaras, John P; Stadtmauer, Edward A.: Melphalan/total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemia. Clinical lymphoma, myeloma & leukemia 14 (6): e225-8,2014.

Stadtmauer, Edward A; Sullivan, Keith M; Marty, Francisco M; Dadwal, Sanjeet S; Papanicolaou, Genovefa A; Shea, Thomas C; Mossad, Sherif B; Andreadis, Charalambos; Young, Jo-Anne H; Buadi, Francis K; El Idrissi, Mohamed; Heineman, Thomas C; Berkowitz, Elchonon M.: A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood 124 (19): 2921-9,2014.

Garfall, A L; Dougherty, A L; Vogl, D T; Weiss, B M; Cohen, A D; Mick, R; O'Doherty, U; Stadtmauer, E A.: Association between mobilization regimen and PFS after auto-SCT for multiple myeloma. Bone Marrow Transplantation 49 (11): 1439-41,2014.

Reshef, Ran; Hexner, Elizabeth O; Loren, Alison W; Frey, Noelle V; Stadtmauer, Edward A; Luger, Selina M; Mangan, James K; Gill, Saar I; Vassilev, Pavel; Lafferty, Kathryn A; Smith, Jacqueline; Van Deerlin, Vivianna M; Mick, Rosemarie; Porter, David L.: Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning. Biology of Blood & Marrow Transplantation 20 (11): 1758-66,2014.

Alsina, Melissa; Becker, Pamela S; Zhong, Xiaobo; Adams, Alexia; Hari, Parameswaran; Rowley, Scott; Stadtmauer, Edward A; Vesole, David H; Logan, Brent; Weisdorf, Daniel; Qazilbash, Muzaffar; Popplewell, Leslie L; McClune, Brian; Bensinger, William; Riches, Marcie; Giralt, Sergio A; Pasquini, Marcelo C; Resource for Clinical Investigation in Blood and Marrow Transplantation.: Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation. Biology of Blood & Marrow Transplantation 20 (8): 1183-9,2014.

Academic Contact Info

2 Perelman Center for Advanced Medicine
34th and Civic Center Bld

Philadelphia, PA 19104
Phone: (215) 662-7910
Fax: (215) 662-4064
Patient appointments: 800-789-PENN (7366)

Related Links